Filing metadata

Accession number
0000899243-22-012967
Form type
Form 3
Filer
Kalaris Therapeutics, Inc.
CIK
CIK 1754068
Filed
Mar 31, 2022
Reporting period
Mar 29, 2022
Description
Initial ownership

Explore SEC Filings Hub